Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Celltrion (068270) Confirms Ex-Rights Reference Price of KRW 179,100 Following Bonus Issue

Posted on June 2, 2026July 14, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) Confirms Ex-Rights Reference Price of KRW 179,100 Following Bonus Issue

Fact Source: Financial Supervisory Service DART / 2026-06-02

Disclosure Type: Guide on Ex-Rights Reference Price

💡 3-Second Summary

Following its bonus issue resolution, Celltrion’s ex-rights reference price for common stock has been formally confirmed at KRW 179,100 per share, effective June 4, 2026.

📊 1. [Summary of Key Disclosure Content and Figures]

  • Company Name: Celltrion Inc.
  • Class of Stock: Common Stock
  • Confirmed Ex-Rights Reference Price: KRW 179,100 per share
  • Reason for Adjustment: Ex-rights technical adjustment triggered by a corporate bonus issue
  • Effective Date: June 4, 2026
  • Regulatory Basis: Article 30 of the Enforcement Rules of the KOSPI Market Business Regulations

📈 2. [Professional Insight: What This Disclosure Means for Investors]

  • Understanding the Technical Ex-Rights Price Drop: A bonus issue increases the total volume of outstanding shares without shifting the net equity of the firm. To counteract this expansion, the exchange executes an “ex-rights” price correction to balance the total market capitalization. While the newly calculated opening price of KRW 179,100 looks like a steep plunge on charting software, this is a routine administrative drop rather than an indicator of fundamental financial stress or negative institutional sell-offs.
  • Neutral Impact on Total Portfolio Value: Although the per-share value trades at a scaled-down floor starting June 4, investors will receive their newly issued bonus shares on the distribution date. Because the share count expands proportionally to the price cut, the total financial asset value of existing accounts remains perfectly insulated. Historically, reducing the nominal share price below historical ceilings can prompt a positive psychological baseline effect, boosting lower-tier liquidity from retail participants.
  • Mandatory Re-calibration of Trading Models: Because any equity purchased on or after June 4, 2026, loses the eligibility to receive the free bonus shares, trading desks must immediately index their algorithmic overlays and valuation ceilings against this new KRW 179,100 marker to eliminate unexpected margins or erroneous derivative orders.

📝 Editor’s Comment (by K-STOCK Editor)

Celltrion’s bonus issue lifecycle has reached its critical execution point with the establishment of the ex-rights opening anchor at KRW 179,100. Global portfolio managers looking at standard domestic trading feeds on June 4 should expect an artificial downward gap in historical price lines. This is purely a mechanical calculation implemented by the Korea Exchange to match the upcoming expansion of the tradeable float. Rather than viewing this as a genuine valuation markdown, institutional desks often analyze this post-ex-rights phase for localized liquidity spikes, as a sub-KRW 180k price tag frequently triggers algorithmic buying programs targeting nominal price drops. Long-term market participants should look past this short-term chart distortion and keep their eyes anchored on the subsequent new share listing schedule.

📢 Disclaimer & Source Information

Source: This content has been structured and newly written based on official disclosure data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Advisory: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice, solicitation, or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Inquiries: For compliance queries or copyright-related requests, please contact us at ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) Announces Stock Futures and Options Market Adjustments Following Bonus Issue Decision
Next Post: [Disclosure] Samsung Electro-Mechanics Preferred (009150) Lifted from ‘Investment Warning’ Status… Re-designation Warned Conditional on Short-term Spikes

Related Posts

[Disclosure] Alteogen (196170) to List 146,140 Additional Common Shares Following Stock Option Exercises Disclosures
[Disclosure] Alteogen (196170) Clarifies Media Report on ‘KRW 200B RCPS Issuance and Shinhan Securities as Lead Manager’: “Under Consideration But Unconfirmed; No Lead Manager Contract Signed” Disclosures
[Disclosure] Celltrion (068270) Submits Application to Modify Phase 3 Clinical Trial Plan for ‘CT-P44’ (Darzalex Biosimilar) in Europe Disclosures
[Disclosure] Alteogen (196170) Clarifies Media Report on ‘KRW 200B RCPS Issuance and Shinhan Securities as Lead Manager’: “Under Consideration But Unconfirmed; No Lead Manager Contract Signed” Disclosures
[Disclosure] Samsung Biologics(207940) Increases Eli Lilly CMO Contract by KRW 256.2B—Total Value Reaches KRW 584.1B Disclosures
[Disclosure] Alteogen (196170) Updates Media Rumor Clarification on ‘KRW 200B RCPS Issuance & Shinhan Securities’: “Financing Options Active But Details Still Unconfirmed; No Contract Signed” Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Celltrion (068270) Submits Application to Modify Phase 3 Clinical Trial Plan for ‘CT-P44’ (Darzalex Biosimilar) in EuropeJuly 14, 2026
  • [Disclosure] Hanmi Semiconductor (042700) Reports Q2 2026 Operating Profit of KRW 130.3B… A Explosive 1,441.4% QoQ SurgeJuly 14, 2026
  • [Disclosure] SK Square (402340) Discloses Subsidiary SK Hynix’s Successful ADR Listing on the U.S. NASDAQ MarketJuly 13, 2026
  • [Disclosure] SK Hynix (000660) Completes Listing of ADRs (American Depositary Receipts) on the U.S. NASDAQ MarketJuly 13, 2026
  • [Disclosure] Samsung Electronics (005930) to Dispose of KRW 322.8B Worth of Treasury Shares for Executive BonusesJuly 13, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme